Pathogenic variants in ANGPTL3 encoding angiopoietin‐like protein 3 are also associated with reduced levels of apo B‐containing lipoproteins and protection from ASCVD, although hepatic involvement has not been consistently demonstrated [8]. Here, APOB is linked to atherosclerosis.